9fin launches comprehensive BDC Watchlist and identifies $5.7 billion of loans held by BDCs 'at risk'

9fin launched a BDC Watchlist identifying $5.7B (fair value) of loans at risk across 157 BDCs, based on Q1 2026 filings—down 17% from $6.9B par value (a $1.2B value erosion). The watchlist flags 468 positions with valuation marks below 90% and highlights that NAV fair value marks are deteriorating (public BDC NAV per share at 92.4% vs Q1 2025; average share price discounts widening from -6.86% to -23.24%). While positioned as an intelligence product, the data point to ongoing credit stress and potential further downside for BDC investors.

Analysis

The key market mechanism is not the existence of stressed credits, but the growing probability that weaker BDCs lose the ability to grow accretively. Once discounts to NAV stay wide, equity issuance becomes punitive, forcing slower asset growth, weaker fee income, and eventually dividend pressure over the next 1-3 quarters. That is why the more levered, more concentrated BDCs are the real losers; the better-capitalized private-credit sponsors are mostly exposed through sentiment and fundraising, not immediate balance-sheet damage.

The second-order spillover is into refinancing terms for sponsor-backed borrowers. Names that are already marked down are the ones most likely to face tighter amendment language, smaller revolvers, and more aggressive pricing on refinancings in the next 1-3 months as Q2/Q3 marks filter through. That can widen spreads in software-heavy leveraged lending and pressure adjacent CLO equity, so the market may be underestimating how quickly fair-value erosion turns into funding friction before true non-accruals rise.

For BX, this looks more like a multiple/optics headwind than a direct earnings hit unless mark deterioration starts impairing fee-bearing AUM or fundraising. PSBD is more vulnerable because its equity is a direct claim on NAV and dividend capacity, so it should trade as a higher-beta expression of the same stress. The contrarian risk is that the market is treating accounting marks as realized losses; if Q2 NAVs stabilize and dividend coverage stays above 1.0x, the current discounting likely overstates the permanent damage.

Key Decisions for Investors

• Short PSBD on any near-term bounce; 1-3 month horizon. Thesis: public BDCs with higher mark sensitivity should keep underperforming as NAV discounts remain punitive. Falsifier: Q2 NAV stabilizes and dividend coverage holds above 1.0x.
• Pair trade: long BX vs short PSBD (or a BDC basket via BIZD) for 1-3 months. Thesis: BX should be insulated by diversified fee streams while weaker BDCs remain trapped by capital-cost pressure. Risk/reward is favorable if credit stress stays contained but the spread can widen materially if discounts keep blowing out.
• Buy 3-month puts on BIZD as a portfolio hedge into the next BDC reporting cycle. Use it only if you need cheap downside protection on broader private-credit sentiment; the trade works if mark erosion continues translating into lower NAVs and wider discounts.
• Do not chase the whole complex lower indiscriminately; instead wait for Q2/Q3 filings to separate stabilizers from laggards. If discounts to NAV compress meaningfully from current extremes and non-accruals do not rise, fade the bearish tape rather than add shorts.